Relay Therapeutics

Relay Therapeutics is a biotechnology startup founded in 2016 and headquartered in the United States. The company's slogan, "Integrating leading-edge computational and experimental science to transform human health," encapsulates its mission to revolutionize the drug discovery process using advanced insights into protein motion and function. Combining computational power with experimental approaches in structural biology, biophysics, chemistry, and biology, Relay Therapeutics aims to develop unique product candidates for novel therapies. In January 2024, the company received a significant investment of $30.00M in post-IPO equity from Nextech Invest. Located in Cambridge, Massachusetts, Relay Therapeutics boasts a world-class team with a passion for making a difference in patients' lives. The company's approach to identifying and advancing drug protein targets based on their motion sets it apart, offering the potential for groundbreaking therapeutic solutions. With its innovative approach and strong investor backing, Relay Therapeutics is poised to make a lasting impact in the field of precision medicines.